dermatan sulfate has been researched along with warfarin in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (9.38) | 18.7374 |
1990's | 8 (25.00) | 18.2507 |
2000's | 16 (50.00) | 29.6817 |
2010's | 5 (15.63) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bergqvist, D | 1 |
Gerhart, TN; Lee, MA; Robertson, LK; Salzman, EW; Smith, M; Yett, HS | 1 |
Bourgondiƫn, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM | 1 |
Andersson, TR | 1 |
Brandt, JT; Ezenagu, LC | 1 |
Boon, DM; Kappers-Klunne, MC; Michiels, JJ; Stibbe, J; van Vliet, HH | 1 |
Augusseau-Richard, MP; Charbonnier, B; Dessenne, X; Pacouret, G; Pagot, O | 1 |
Comp, PC; McCutchen, JW; Overdyke, WL; Skoutakis, VA; Trowbridge, A; Voegeli, T | 1 |
Warkentin, TE | 5 |
Jang, IK; Januzzi, JL | 1 |
Barratt, SM; Edwards, RC; Ruff, SJ | 1 |
Ignaszewski, AP; Pamboukian, SV; Ross, HJ | 1 |
Arthur, C; Cade, JF; Chesterman, CN; Chong, BH; Gallo, J; Gallus, AS; Lloyd, J; Magnani, H; Manoharan, A; Oldmeadow, M; Rickard, K; Seshadri, P | 1 |
Bauersachs, R; Lindhoff-Last, E | 1 |
Da Silva, MS; Sobel, M | 1 |
Myers, B; Strong, J; Westby, J | 1 |
Carnelli, V; Gatti, L; Moia, M; Rusconi, R | 1 |
Carman, TL; Farray, D; Fernandez, BB | 1 |
Bourke, M; Lavalee, G; Mesana, T; Rubens, FD; Ruel, MA | 1 |
Bartholomew, JR | 1 |
Greinacher, A; Krahn, EL; Lubenow, N; Magnani, HN; Sloane, DA; Warkentin, TE; Wessel, A | 1 |
Ahmed, I; Majeed, A; Powell, R | 1 |
Chong, BH; Isaacs, A | 1 |
Hamada, K; Nakazawa, T; Nawata, Y; Nishino, N; Saitoh, S; Tajima, H; Tobayashi, K | 1 |
Giannubilo, SR; Tranquilli, AL | 1 |
Akahoshi, T; Harimoto, N; Iguchi, T; Itoh, S; Kawanaka, H; Maehara, Y; Shirabe, K; Takenaka, K; Uchiyama, H; Yoshizumi, T | 1 |
Akuta, N; Arase, Y; Fujiyama, S; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y | 1 |
12 review(s) available for dermatan sulfate and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Limitations of conventional treatment options for heparin-induced thrombocytopenia.
Topics: Ancrod; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Thrombocytopenia; Warfarin | 1998 |
Heparin-induced thrombocytopenia: a ten-year retrospective.
Topics: Antibodies; Anticoagulants; Antithrombin III; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Gangrene; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Immunoglobulin G; Leg; Platelet Activation; Platelet Factor 4; Protein C Deficiency; Receptors, IgG; Recombinant Proteins; Retrospective Studies; Syndrome; Thrombin; Thrombocytopenia; Venous Thrombosis; Warfarin | 1999 |
Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management.
Topics: Ancrod; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Forecasting; Gangrene; Hemorrhage; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation; Protein C; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin | 1999 |
Venous thromboembolism in heparin-induced thrombocytopenia.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Humans; Leg; Pulmonary Embolism; Thrombocytopenia; Venous Thrombosis; Warfarin | 2000 |
Current agents for the treatment of patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Autoimmune Diseases; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Warfarin | 2002 |
Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Humans; Lactation; Pregnancy; Pregnancy Complications; Thrombocytopenia; Warfarin | 2002 |
Anticoagulants: to bleed or not to bleed, that is the question.
Topics: Anticoagulants; Arteriosclerosis; Blood Coagulation; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Platelet Activation; Thrombin; Thromboembolism | 2002 |
The treatment and prevention of deep vein thrombosis in the preoperative management of patients who have neurologic diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Brain Diseases; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Postoperative Complications; Venous Thrombosis; Warfarin | 2004 |
Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
Topics: Administration, Oral; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Factors; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Hirudins; Humans; Ischemia; Leg; Necrosis; Pipecolic Acids; Recombinant Proteins; Skin; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2005 |
Heparin induced thrombocytopenia: diagnosis and management update.
Topics: Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Renal Dialysis; Sulfonamides; Thrombocytopenia; Warfarin | 2007 |
Heparin-induced thrombocytopenia: what clinicians need to know.
Topics: Anticoagulants; Arginine; Autoantibodies; Chondroitin Sulfates; Dermatan Sulfate; Drug Monitoring; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2009 |
5 trial(s) available for dermatan sulfate and warfarin
Article | Year |
---|---|
Orgaran in hip fracture surgery.
Topics: Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Female; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Hip Fractures; Humans; Incidence; Male; Postoperative Complications; Pulmonary Embolism; Scandinavian and Nordic Countries; Single-Blind Method; Thrombophlebitis; United States; Warfarin | 1992 |
Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial.
Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparinoids; Heparitin Sulfate; Hip Fractures; Humans; Iodine Radioisotopes; Male; Middle Aged; Molecular Weight; Plethysmography; Postoperative Complications; Prevalence; Prospective Studies; Risk Factors; Thrombophlebitis; Warfarin | 1991 |
A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement: The Danaparoid Hip Arthroplasty Investigators Group.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparitin Sulfate; Humans; Male; Middle Aged; Postoperative Complications; Single-Blind Method; Treatment Outcome; Venous Thrombosis; Warfarin | 1998 |
Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study.
Topics: Aged; Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Drug Combinations; Drug Therapy, Combination; Female; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Prospective Studies; Survival Rate; Therapeutic Equivalency; Thrombocytopenia; Thrombosis; Treatment Outcome; Warfarin | 2001 |
Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension.
Topics: Adult; Aged; Anticoagulants; Antithrombin III; Chondroitin Sulfates; Clinical Protocols; Decision Support Techniques; Dermatan Sulfate; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparitin Sulfate; Humans; Hypertension, Portal; Laparoscopy; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Postoperative Complications; Prospective Studies; Risk Assessment; Risk Factors; ROC Curve; Splenectomy; Venous Thrombosis; Warfarin | 2014 |
15 other study(ies) available for dermatan sulfate and warfarin
Article | Year |
---|---|
Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation Factors; Blood Platelets; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Disease Models, Animal; Fibrin; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Immune Sera; Ligation; Male; Oligosaccharides; Rats; Thrombosis; Venae Cavae; Vitamin K | 1989 |
Consumption of heparin cofactor II (dermatan sulfate cofactor) and antithrombin during coagulation.
Topics: Antithrombins; Blood Coagulation; Dermatan Sulfate; Disseminated Intravascular Coagulation; Glycoproteins; Heparin; Heparin Cofactor II; Humans; In Vitro Techniques; Liver Diseases; Warfarin | 1987 |
Laboratory determination of heparin cofactor II.
Topics: Antithrombin III; Antithrombin III Deficiency; Antithrombins; Dermatan Sulfate; Disseminated Intravascular Coagulation; Female; Glycoproteins; Heparin Cofactor II; Humans; Liver Diseases; Methods; Pre-Eclampsia; Pregnancy; Thrombosis; Warfarin | 1986 |
Heparin-induced thrombocytopenia and antithrombotic therapy.
Topics: Adolescent; Adult; Aged; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombocytopenia; Treatment Outcome; Warfarin | 1994 |
[Anticoagulant therapy in pulmonary embolism].
Topics: Anticoagulants; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Drug Administration Schedule; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Humans; Injections, Intravenous; Partial Thromboplastin Time; Pulmonary Embolism; Thrombolytic Therapy; Thrombosis; Treatment Outcome | 1995 |
Heparin-induced thrombocytopenia and its treatment.
Topics: Ancrod; Anticoagulants; Antithrombins; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Recombinant Proteins; Thrombocytopenia; Thrombosis; Warfarin | 2000 |
Heparin-induced thrombocytopenia presenting after the cessation of low molecular weight heparin prophylaxis with enoxaparin.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Enoxaparin; Female; Heparitin Sulfate; Humans; Middle Aged; Platelet Count; Radionuclide Imaging; Thrombocytopenia; Warfarin | 2000 |
Management strategies for heparin-induced thrombocytopenia in heart-transplant candidates: case report and review of the literature.
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Fatal Outcome; Female; Heart Transplantation; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Partial Thromboplastin Time; Platelet Count; Thrombocytopenia; Warfarin | 2000 |
Prophylactic use of danaparoid in high-risk pregnancy with heparin-induced thrombocytopaenia-positive skin reaction.
Topics: Adult; Anticoagulants; Cesarean Section; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Eruptions; Emergencies; Female; Heparin; Heparitin Sulfate; Humans; Infant, Newborn; Injections, Subcutaneous; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy, High-Risk; Pregnancy, Multiple; Puerperal Disorders; Pulmonary Embolism; Thrombocytopenia; Thrombosis; Warfarin | 2003 |
Heparin-induced thrombocytopenia and warfarin-induced skin necrosis in a child with severe protein C deficiency: successful treatment with dermatan sulfate and protein C concentrate.
Topics: Anticoagulants; Child; Dermatan Sulfate; Heparin; Humans; Male; Necrosis; Protein C; Protein C Deficiency; Skin; Thrombocytopenia; Warfarin | 2003 |
Delayed thrombin generation with hirudin anticoagulation during prolonged cardiopulmonary bypass.
Topics: Aged; Anticoagulants; Blood Coagulation; Cardiopulmonary Bypass; Chondroitin Sulfates; Contraindications; Dermatan Sulfate; Endarterectomy; Female; Heparin; Heparitin Sulfate; Hirudins; Humans; Hypertension, Pulmonary; Plasma; Platelet Transfusion; Pulmonary Embolism; Recombinant Proteins; Thrombectomy; Thrombin; Thrombocytopenia; Time Factors; Warfarin | 2005 |
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s.
Topics: Aged; Ancrod; Canada; Chondroitin Sulfates; Cohort Studies; Coumarins; Dermatan Sulfate; Female; Germany; Heparin; Heparitin Sulfate; Humans; Male; Outcome Assessment, Health Care; Platelet Count; Practice Patterns, Physicians'; Retrospective Studies; Survival Analysis; Thrombocytopenia | 2006 |
[Successful use of danaparoid in the treatment of portal vein thrombosis that developed in a warfarin-administered hepatitis C virus-related cirrhosis patient].
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparitin Sulfate; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Portal Vein; Thrombosis; Warfarin | 2012 |
Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia.
Topics: Anticoagulants; Aspirin; Bone Density; Breast Feeding; Chondroitin Sulfates; Dermatan Sulfate; Female; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Infant, Newborn; Polysaccharides; Pregnancy; Pregnancy Complications, Hematologic; Thromboembolism; Thrombophilia; Warfarin | 2012 |
Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Chondroitin Sulfates; Contrast Media; Dermatan Sulfate; Female; Heparitin Sulfate; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Recurrence; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis; Warfarin | 2017 |